File:41541 2019 132 Fig1 HTML.webp
Size of this PNG preview of this WEBP file: 676 × 599 pixels. Other resolutions: 271 × 240 pixels | 541 × 480 pixels | 866 × 768 pixels | 1,155 × 1,024 pixels | 1,323 × 1,173 pixels.
Original file (1,323 × 1,173 pixels, file size: 96 KB, MIME type: image/webp)
 | This is a file from the Wikimedia Commons. Information from its description page there is shown below. Commons is a freely licensed media file repository. You can help. |
Summary
| Description |
English: Summary of expected biological mechanisms underlying the development of reactogenicity symptoms. Vaccine antigens and immune enhancers (as adjuvants) injected into the muscle are recognised by the body as potential pathogens and/or danger signals. This recognition leads to the stimulation of local cells, followed by the recruitment of blood immune cells to the local site and the production of different soluble factors including vasodilators and cytokines, which may trigger the development of signs and symptoms of local inflammation (pain, redness and swelling). The passage of some of those factors in the bloodstream, as well as the production of other systemic factors by immune blood cells or distant organs (e.g. liver), may contribute to the development of general symptoms (fever, myalgia, headache etc) in the vaccinee. CRP C-reactive protein |
| Date | |
| Source | Hervé, C., Laupèze, B., Del Giudice, G. et al. The how’s and what’s of vaccine reactogenicity. npj Vaccines 4, 39 (2019). https://doi.org/10.1038/s41541-019-0132-6 |
| Author | Caroline Hervé, Béatrice Laupèze, Giuseppe Del Giudice, Arnaud M. Didierlaurent, and Fernanda Tavares Da Silva |
Licensing
This file is licensed under the Creative Commons Attribution 4.0 International license.
- You are free:
- to share – to copy, distribute and transmit the work
- to remix – to adapt the work
- Under the following conditions:
- attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
File history
Click on a date/time to view the file as it appeared at that time.
| Date/Time | Thumbnail | Dimensions | User | Comment | |
|---|---|---|---|---|---|
| current | 10:33, 6 October 2021 | | 1,323 × 1,173 (96 KB) | Guest2625 | Uploaded a work by Caroline Hervé, Béatrice Laupèze, Giuseppe Del Giudice, Arnaud M. Didierlaurent, and Fernanda Tavares Da Silva from Hervé, C., Laupèze, B., Del Giudice, G. et al. The how’s and what’s of vaccine reactogenicity. npj Vaccines 4, 39 (2019). https://doi.org/10.1038/s41541-019-0132-6 with UploadWizard |
File usage
The following 2 pages use this file:
